Unknown

Dataset Information

Early improvement with lithium in classic mania and its association with later response.


ABSTRACT:

Objectives

Despite lithium's clinical efficacy in treating mania in bipolar disorder (BD), studies evaluating early improvement and subsequent treatment response are sparse. This study investigated whether early improvement (within one week) to lithium monotherapy predicted later response and remission in individuals with BD mania.

Methods

BD-I patients (n=46) experiencing a manic episode received lithium monotherapy for four weeks (initial dose: 600mg/d, adjusted to therapeutic levels); individuals experiencing a mixed episode, rapid cyclers, previous non-responders to lithium, and those with current drug abuse/dependence were excluded. Symptoms were rated using the Young Mania Rating Scale (YMRS) at baseline and at Days 7, 14, 21, and 28.

Results

Thirty-three percen

SUBMITTER: Machado-Vieira R 

PROVIDER: S-EPMC3513550 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature